Biotechnology
Breaking News
Market News
Technology
The Market Buzz
Breaking News: Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) a clinical stage pharmaceutical development company, is pleased to announce that it has received approval from the Ministry of Food and Drug Safety...
